Teva Announces Proposed Acquisition of BioXcel Neuroscience Asset in Court-Supervised Sale

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray has advised Teva Pharmaceuticals. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has announced its proposed acquisition of certain neuroscience assets from BioXcel Therapeutics, Inc….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here